drugset
drugset / Trial / NCT06689358

Thoracic Paravertebral Block for Postoperative Pain Management After VATS

NCT06689358 ↗

Completed 81 enrolled King Hussein Cancer Center
RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized controlled trial evaluated the efficacy of a thoracic paravertebral block (TPVB) in reducing opioid requirements and pain intensity in the PACU after video-assisted thoracoscopic surgery (VATS).

Timeline

Start
2022-11-01
Primary completion
2024-08-01
Completion
2024-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.5 % Other

Indications

neuropathy, painful